7th Apr 2014 14:25
7 April 2014
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Director / PDMR shareholding
Grant of SAYE options:
Dechra Pharmaceuticals PLC announces that on 7 April 2014, the following Directors and PDMRs were granted options over ordinary shares of 1p each in the Companypursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the "Options").
The Options have been granted with an exercise price of £5.52.
Name | Capacity | Options Granted |
Ian Page | Director | 1,630 |
Anne-Francoise Nesmes | Director | 1,630 |
Zoe Goulding | PDMR | 652 |
For further information, please contact:
Zoe Goulding, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
Related Shares:
DPH.L